Invention Grant
- Patent Title: Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
-
Application No.: US14394161Application Date: 2013-04-12
-
Publication No.: US09610250B2Publication Date: 2017-04-04
- Inventor: Tarek M. Fahmy , Eric Stern , Richard A. Flavell , Jason Park , Alyssa Siefert , Stephen H. Wrzesinski
- Applicant: Yale University
- Applicant Address: US CT New Haven
- Assignee: Yale University
- Current Assignee: Yale University
- Current Assignee Address: US CT New Haven
- Agency: Pabst Patent Group LLP
- International Application: PCT/US2013/036487 WO 20130412
- International Announcement: WO2013/155487 WO 20131017
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K47/24 ; A61K47/40 ; A61K47/48 ; B82Y5/00 ; A61K38/18 ; A61K38/20 ; A61K31/343

Abstract:
A “nanolipogel” is a delivery vehicle including one or more lipid layer surrounding a hydrogel core, which may include an absorbent such as a cyclodextrin or ion-exchange resin. Nanolipogels can be constructed so as to incorporate a variety of different chemical entities that can subsequently be released in a controlled fashion. These different incorporated chemical entities can differ dramatically with respect to size and composition. Nanolipogels have been constructed to contain co-encapsulated proteins as well as small hydrophobic drugs within the interior of the lipid bilayer. Agents incorporated within nanolipogels can be released into the milieu in a controlled fashion, for example, nanolipogels provide a means of achieving simultaneous sustained release of agents that differ widely in chemical composition and molecular weight. Additionally, nanolipogels can favorably modulate biodistribution.
Public/Granted literature
- US20150064265A1 Vehicles for Controlled Delivery of Different Pharmaceutical Agents Public/Granted day:2015-03-05
Information query